依普利酮国内的价格是多少？

(Eplerenone) is a steroidal antimineralocorticoid of the spironolactone group used as an adjunct in the treatment of chronic heart failure and hypertension, especially in patients with drug-resistant hypertension caused by elevated aldosterone. Classified as a selective aldosterone receptor antagonist (SARA), it is similar to the diuretic spironolactone, although it is more selective for the mineralocorticoid receptor, i.e. does not possess any antiandrogenic, progestogenic, glucocorticoid or estrogenic effects, and is particularly promoted for reducing cardiovascular risk in patients following myocardial infarction. Eplerenone is a potassium-sparing diuretic, which means it helps the body get rid of water but still retain potassium. Eplerenone was patented in 1983 and approved for medical use in the United States in 2002.

Clinical trials have shown that eplerenone has a stronger aldosterone antagonism than spironolactone, has extremely low affinity for androgen and progesterone receptors, and has few adverse reactions. It has definite efficacy in the treatment of hypertension, heart failure and myocardial infarction, has fewer adverse reactions, and is well tolerated. It is a good alternative to spironolactone. In addition to the therapeutic effect, what patients are most concerned about is the price of eplerenone. Is eplerenone on the market in China? What is the price in China?

It is understood that up to now, Eplerenone has not been launched in China, so we have no way of knowing the price of Eplerenone. Fortunately, Eplerenone has been launched in India. Eplerenone is produced by Lupine Pharmaceuticals in India. The specification of Eplerenone is 50mg*100 tablets. The price is equivalent to RMB 500, which is cheaper than the original drug. Due to the floating exchange rate, the price is not fixed. For the specific price of Eplerenone, please consult Medical Travel.